Medtronic (MDT) Acquires Affera

Medtronic (MDT) Granted Japanese Approval for Micra AV Transcatheter Pacing System, Will Launch Later this Month

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra AV Transcatheter Pacing System (TPS), and the company will launch the product this month.

This approval expands the number of patients in Japan one of the largest markets in the world who are eligible to receive the Micra TPS, the world's smallest pacemaker. The Micra AV is indicated for the treatment of patients with AV block, a condition in which the... More

BTIG Downgrades Medtronic, Inc. (MDT) to Neutral

BTIG analyst Sean Lavin downgraded Medtronic, Inc. (NYSE: MDT) from Buy to Neutral.

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $105.16 yesterday.

Medtronic, Inc. (MDT) PT Lowered to $128 at Stifel

Stifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $128.00 (from $138.00) while maintaining a Buy rating.... More

UPDATE: Morgan Stanley Downgrades Medtronic, Inc. (MDT) to Equalweight

(Updated - January 7, 2022 4:56 AM EST)

Morgan Stanley analyst Cecilia Furlong downgraded Medtronic, Inc. (NYSE: MDT) from Overweight to Equalweight with a price target of $120.00 (from $145.00).

The analyst comments "We are downgrading Medtronic to Equal-weight from Overweight and lowering our price target to $120 from $145. Our long-term bias remains... More

Medtronic (MDT) call put ratio 3 calls to 1 put

Medtronic (NYSE: MDT) 30-day option implied volatility is at 22; compared to its 52-week range of 15 to 35 into the annual J.P. Morgan Healthcare Conference. Call put ratio 3 calls to 1 put.